Exact Sciences Expects 10% Growth in Q4 Revenue

MT Newswires Live
13 Jan

Exact Sciences (EXAS) said Sunday it expects to report Q4 revenue of $713 million, up 10% from a year earlier.

Analysts polled by FactSet are expecting $696.9 million.

For full-year 2024, the company expects revenue to increase by 10% to $2.76 billion.

Analysts polled by FactSet are expecting $2.74 billion.

The company plans to report earnings in February.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10